Overview

Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous sulopenem and oral sulopenem etzadroxil/probenecid in adolescent patients.
Phase:
Phase 1
Details
Lead Sponsor:
Iterum Therapeutics, International Limited